nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxymetazoline—HTR2A—sympathetic nervous system—adrenal gland cancer	0.0202	0.169	CbGeAlD
Oxymetazoline—HTR2A—vein—adrenal gland cancer	0.0189	0.159	CbGeAlD
Oxymetazoline—HTR2A—urine—adrenal gland cancer	0.0111	0.0928	CbGeAlD
Oxymetazoline—NISCH—adrenal cortex—adrenal gland cancer	0.00948	0.0793	CbGeAlD
Oxymetazoline—NISCH—pituitary gland—adrenal gland cancer	0.00766	0.0641	CbGeAlD
Oxymetazoline—NISCH—adrenal gland—adrenal gland cancer	0.00685	0.0573	CbGeAlD
Oxymetazoline—HTR2B—adrenal cortex—adrenal gland cancer	0.0055	0.046	CbGeAlD
Oxymetazoline—ADRA2C—adrenal cortex—adrenal gland cancer	0.00433	0.0362	CbGeAlD
Oxymetazoline—HTR2B—adrenal gland—adrenal gland cancer	0.00397	0.0332	CbGeAlD
Oxymetazoline—ADRA2C—cardiac atrium—adrenal gland cancer	0.00358	0.03	CbGeAlD
Oxymetazoline—ADRA2C—pituitary gland—adrenal gland cancer	0.0035	0.0293	CbGeAlD
Oxymetazoline—ADRA1A—adrenal gland—adrenal gland cancer	0.00328	0.0275	CbGeAlD
Oxymetazoline—ADRA2C—adrenal gland—adrenal gland cancer	0.00313	0.0262	CbGeAlD
Oxymetazoline—ADRA2A—gonad—adrenal gland cancer	0.00286	0.0239	CbGeAlD
Oxymetazoline—ADRA2A—cardiac atrium—adrenal gland cancer	0.00286	0.0239	CbGeAlD
Oxymetazoline—ADRA2A—pituitary gland—adrenal gland cancer	0.00279	0.0234	CbGeAlD
Oxymetazoline—ADRA2A—adrenal gland—adrenal gland cancer	0.0025	0.0209	CbGeAlD
Oxymetazoline—HTR2A—gonad—adrenal gland cancer	0.00243	0.0204	CbGeAlD
Oxymetazoline—HTR2A—pituitary gland—adrenal gland cancer	0.00237	0.0199	CbGeAlD
Oxymetazoline—HTR2A—adrenal gland—adrenal gland cancer	0.00212	0.0177	CbGeAlD
Oxymetazoline—ADRA2B—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000583	0.000662	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—IGF1R—adrenal gland cancer	0.000582	0.000661	CbGpPWpGaD
Oxymetazoline—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.000581	0.00066	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—GNRH1—adrenal gland cancer	0.000579	0.000658	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR ligand binding—POMC—adrenal gland cancer	0.000579	0.000658	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00057	0.000647	CbGpPWpGaD
Oxymetazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.000569	0.000646	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR ligand binding—POMC—adrenal gland cancer	0.000567	0.000644	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—GNRH1—adrenal gland cancer	0.000563	0.00064	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000561	0.000637	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—MEN1—adrenal gland cancer	0.00056	0.000636	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00056	0.000636	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—GNRH1—adrenal gland cancer	0.000555	0.00063	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—CDC42—adrenal gland cancer	0.000554	0.000629	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—SPRY2—adrenal gland cancer	0.000552	0.000627	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000545	0.000619	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000545	0.000618	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—TSHR—adrenal gland cancer	0.000538	0.000611	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000536	0.000609	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000533	0.000606	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—CDC42—adrenal gland cancer	0.000532	0.000604	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—SPRY2—adrenal gland cancer	0.00053	0.000602	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—GNAS—adrenal gland cancer	0.000529	0.000601	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR ligand binding—POMC—adrenal gland cancer	0.000527	0.000599	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—CDC42—adrenal gland cancer	0.000518	0.000588	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—TSHR—adrenal gland cancer	0.000516	0.000586	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—SPRY2—adrenal gland cancer	0.000515	0.000585	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—CDC42—adrenal gland cancer	0.000509	0.000578	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000509	0.000578	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—GNAS—adrenal gland cancer	0.000508	0.000577	CbGpPWpGaD
Oxymetazoline—HTR1D—GPCR downstream signaling—POMC—adrenal gland cancer	0.000508	0.000577	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—SPRY2—adrenal gland cancer	0.000507	0.000576	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—MEN1—adrenal gland cancer	0.000505	0.000574	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—GNRH1—adrenal gland cancer	0.000503	0.000571	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—TSHR—adrenal gland cancer	0.000502	0.00057	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—TERT—adrenal gland cancer	0.000501	0.000569	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—PRKACA—adrenal gland cancer	0.000499	0.000567	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000498	0.000566	CbGpPWpGaD
Oxymetazoline—HTR1B—GPCR downstream signaling—POMC—adrenal gland cancer	0.000497	0.000565	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000496	0.000563	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—GNAS—adrenal gland cancer	0.000494	0.000562	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—TSHR—adrenal gland cancer	0.000494	0.000561	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—GNRH1—adrenal gland cancer	0.000493	0.000559	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—PRKACA—adrenal gland cancer	0.000489	0.000555	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—GNAS—adrenal gland cancer	0.000487	0.000553	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000486	0.000552	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—MEN1—adrenal gland cancer	0.000485	0.000551	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—MED12—adrenal gland cancer	0.00048	0.000545	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000476	0.000541	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—MEN1—adrenal gland cancer	0.000472	0.000536	CbGpPWpGaD
Oxymetazoline—HTR2B—GPCR downstream signaling—POMC—adrenal gland cancer	0.000467	0.000531	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—MEN1—adrenal gland cancer	0.000465	0.000528	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000463	0.000526	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—CDC42—adrenal gland cancer	0.000462	0.000525	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling by GPCR—POMC—adrenal gland cancer	0.000461	0.000524	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—SPRY2—adrenal gland cancer	0.00046	0.000523	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—PRKACA—adrenal gland cancer	0.000459	0.000522	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—GNRH1—adrenal gland cancer	0.000458	0.00052	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—CDC42—adrenal gland cancer	0.000452	0.000514	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling by GPCR—POMC—adrenal gland cancer	0.000452	0.000513	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—SPRY2—adrenal gland cancer	0.00045	0.000512	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—TSHR—adrenal gland cancer	0.000448	0.000509	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000442	0.000502	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—GNAS—adrenal gland cancer	0.000441	0.000501	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—TSHR—adrenal gland cancer	0.000439	0.000499	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—BAD—adrenal gland cancer	0.000436	0.000495	CbGpPWpGaD
Oxymetazoline—ADRA1D—GPCR downstream signaling—POMC—adrenal gland cancer	0.000435	0.000494	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—GNAS—adrenal gland cancer	0.000432	0.000491	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—PRKACA—adrenal gland cancer	0.000431	0.00049	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—PRKACA—adrenal gland cancer	0.000427	0.000485	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling by GPCR—POMC—adrenal gland cancer	0.000424	0.000482	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—CDC42—adrenal gland cancer	0.000424	0.000481	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—MEN1—adrenal gland cancer	0.000422	0.000479	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—CDC42—adrenal gland cancer	0.00042	0.000477	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—SPRY2—adrenal gland cancer	0.000419	0.000475	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—CDC42—adrenal gland cancer	0.000415	0.000471	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—MEN1—adrenal gland cancer	0.000413	0.000469	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—IGF2—adrenal gland cancer	0.000408	0.000464	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—TSHR—adrenal gland cancer	0.000408	0.000463	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—GNAS—adrenal gland cancer	0.000405	0.00046	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—POMC—adrenal gland cancer	0.000402	0.000457	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—GNAS—adrenal gland cancer	0.000402	0.000456	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—IGF2—adrenal gland cancer	0.0004	0.000454	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—BRAF—adrenal gland cancer	0.000397	0.000451	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—GNAS—adrenal gland cancer	0.000396	0.00045	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—POMC—adrenal gland cancer	0.000395	0.000448	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—IGF1R—adrenal gland cancer	0.000395	0.000448	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCR downstream signaling—POMC—adrenal gland cancer	0.000393	0.000446	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—CDC42—adrenal gland cancer	0.00039	0.000442	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—IGF1R—adrenal gland cancer	0.000387	0.000439	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—PRKACA—adrenal gland cancer	0.000386	0.000438	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling by GPCR—EGFR—adrenal gland cancer	0.000385	0.000437	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—MEN1—adrenal gland cancer	0.000384	0.000436	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR downstream signaling—POMC—adrenal gland cancer	0.000377	0.000428	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—IGF2—adrenal gland cancer	0.000376	0.000427	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—GNAS—adrenal gland cancer	0.000372	0.000423	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—PRKACA—adrenal gland cancer	0.000371	0.000421	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR downstream signaling—POMC—adrenal gland cancer	0.000367	0.000416	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—IGF1R—adrenal gland cancer	0.000363	0.000412	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—CDC42—adrenal gland cancer	0.000363	0.000412	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR downstream signaling—POMC—adrenal gland cancer	0.000361	0.00041	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—PRKACA—adrenal gland cancer	0.00036	0.000409	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—POMC—adrenal gland cancer	0.000356	0.000405	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—PRKACA—adrenal gland cancer	0.000355	0.000403	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—PRKACA—adrenal gland cancer	0.00035	0.000398	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—IGF2—adrenal gland cancer	0.000349	0.000397	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—GNAS—adrenal gland cancer	0.000349	0.000397	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—GNAS—adrenal gland cancer	0.000346	0.000393	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—ABCB1—adrenal gland cancer	0.000343	0.000389	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—POMC—adrenal gland cancer	0.000342	0.000389	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—TERT—adrenal gland cancer	0.00034	0.000386	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—IGF1R—adrenal gland cancer	0.000338	0.000384	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—POMC—adrenal gland cancer	0.000333	0.000378	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—TERT—adrenal gland cancer	0.000333	0.000378	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—POMC—adrenal gland cancer	0.000328	0.000372	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR downstream signaling—POMC—adrenal gland cancer	0.000327	0.000372	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—CDC42—adrenal gland cancer	0.000327	0.000372	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000322	0.000365	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—POMC—adrenal gland cancer	0.000321	0.000364	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—IGF2—adrenal gland cancer	0.000315	0.000358	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000315	0.000358	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—CDC42—adrenal gland cancer	0.000314	0.000357	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—GNAS—adrenal gland cancer	0.000313	0.000355	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—TERT—adrenal gland cancer	0.000313	0.000355	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—CDC42—adrenal gland cancer	0.000306	0.000347	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—IGF1R—adrenal gland cancer	0.000305	0.000346	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—IGF2—adrenal gland cancer	0.000303	0.000344	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—CDC42—adrenal gland cancer	0.000301	0.000342	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—GNAS—adrenal gland cancer	0.0003	0.000341	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—POMC—adrenal gland cancer	0.000298	0.000338	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—POMC—adrenal gland cancer	0.000297	0.000338	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—BAD—adrenal gland cancer	0.000296	0.000336	CbGpPWpGaD
Oxymetazoline—ADRA2B—Hemostasis—TP53—adrenal gland cancer	0.000295	0.000335	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—IGF2—adrenal gland cancer	0.000295	0.000335	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—IGF1R—adrenal gland cancer	0.000293	0.000333	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000293	0.000332	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—GNAS—adrenal gland cancer	0.000292	0.000332	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—POMC—adrenal gland cancer	0.000291	0.000331	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—TERT—adrenal gland cancer	0.000291	0.00033	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—IGF2—adrenal gland cancer	0.00029	0.000329	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—BAD—adrenal gland cancer	0.000289	0.000329	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—GNAS—adrenal gland cancer	0.000287	0.000327	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000287	0.000326	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—IGF1R—adrenal gland cancer	0.000285	0.000324	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—GNAS—adrenal gland cancer	0.000284	0.000322	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—IGF1R—adrenal gland cancer	0.00028	0.000318	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—ABCB1—adrenal gland cancer	0.000278	0.000316	CbGpPWpGaD
Oxymetazoline—ADRA2C—Hemostasis—TP53—adrenal gland cancer	0.000275	0.000313	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—CDC42—adrenal gland cancer	0.000273	0.00031	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—POMC—adrenal gland cancer	0.000273	0.00031	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—BAD—adrenal gland cancer	0.000272	0.000309	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—POMC—adrenal gland cancer	0.00027	0.000307	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—BRAF—adrenal gland cancer	0.000269	0.000306	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—CDC42—adrenal gland cancer	0.000267	0.000304	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—POMC—adrenal gland cancer	0.000267	0.000303	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—BRAF—adrenal gland cancer	0.000263	0.000299	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—IGF2—adrenal gland cancer	0.000263	0.000299	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—TERT—adrenal gland cancer	0.000263	0.000298	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling by GPCR—EGFR—adrenal gland cancer	0.000261	0.000296	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—GNAS—adrenal gland cancer	0.000261	0.000296	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—IGF2—adrenal gland cancer	0.000258	0.000293	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling by GPCR—EGFR—adrenal gland cancer	0.000255	0.00029	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—GNAS—adrenal gland cancer	0.000255	0.00029	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000254	0.000289	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—BAD—adrenal gland cancer	0.000253	0.000287	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—TERT—adrenal gland cancer	0.000252	0.000286	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—POMC—adrenal gland cancer	0.000251	0.000285	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000249	0.000283	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—CDC42—adrenal gland cancer	0.000248	0.000282	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—BRAF—adrenal gland cancer	0.000248	0.000281	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—TERT—adrenal gland cancer	0.000245	0.000279	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—TERT—adrenal gland cancer	0.000241	0.000274	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling by GPCR—EGFR—adrenal gland cancer	0.00024	0.000272	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—IGF2—adrenal gland cancer	0.000239	0.000272	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—GNAS—adrenal gland cancer	0.000237	0.000269	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—POMC—adrenal gland cancer	0.000235	0.000267	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—POMC—adrenal gland cancer	0.000233	0.000265	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000231	0.000263	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—BRAF—adrenal gland cancer	0.00023	0.000262	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—BAD—adrenal gland cancer	0.000228	0.000259	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—EGFR—adrenal gland cancer	0.000227	0.000258	CbGpPWpGaD
Oxymetazoline—ADRA2A—Hemostasis—TP53—adrenal gland cancer	0.000224	0.000254	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—EGFR—adrenal gland cancer	0.000223	0.000254	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—BAD—adrenal gland cancer	0.000219	0.000249	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—TERT—adrenal gland cancer	0.000219	0.000249	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—TERT—adrenal gland cancer	0.000214	0.000244	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—BAD—adrenal gland cancer	0.000213	0.000242	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—POMC—adrenal gland cancer	0.000211	0.000239	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—BAD—adrenal gland cancer	0.00021	0.000238	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—BRAF—adrenal gland cancer	0.000208	0.000236	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—POMC—adrenal gland cancer	0.000202	0.00023	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—EGFR—adrenal gland cancer	0.000202	0.000229	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—BRAF—adrenal gland cancer	0.0002	0.000227	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—TERT—adrenal gland cancer	0.000199	0.000226	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—POMC—adrenal gland cancer	0.000197	0.000223	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000194	0.000221	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—BRAF—adrenal gland cancer	0.000194	0.000221	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—POMC—adrenal gland cancer	0.000194	0.00022	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—EGFR—adrenal gland cancer	0.000194	0.00022	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—BRAF—adrenal gland cancer	0.000191	0.000217	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—POMC—adrenal gland cancer	0.000191	0.000217	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—TP53—adrenal gland cancer	0.000191	0.000217	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—BAD—adrenal gland cancer	0.00019	0.000216	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—CTNNB1—adrenal gland cancer	0.00019	0.000216	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—EGFR—adrenal gland cancer	0.000188	0.000214	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—PTGS2—adrenal gland cancer	0.000188	0.000213	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—BAD—adrenal gland cancer	0.000187	0.000212	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—EGFR—adrenal gland cancer	0.000185	0.00021	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000179	0.000203	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—POMC—adrenal gland cancer	0.000176	0.000199	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—BRAF—adrenal gland cancer	0.000173	0.000197	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—BAD—adrenal gland cancer	0.000173	0.000197	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—POMC—adrenal gland cancer	0.000172	0.000195	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—BRAF—adrenal gland cancer	0.00017	0.000193	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—EGFR—adrenal gland cancer	0.000168	0.000191	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000166	0.000189	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—EGFR—adrenal gland cancer	0.000165	0.000187	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—POMC—adrenal gland cancer	0.00016	0.000181	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—BRAF—adrenal gland cancer	0.000158	0.000179	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—EGFR—adrenal gland cancer	0.000154	0.000175	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—EGFR—adrenal gland cancer	0.000153	0.000174	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—PTGS2—adrenal gland cancer	0.000152	0.000173	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—EGFR—adrenal gland cancer	0.000151	0.000171	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—CTNNB1—adrenal gland cancer	0.00015	0.000171	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000144	0.000164	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—EGFR—adrenal gland cancer	0.000142	0.000161	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—CTNNB1—adrenal gland cancer	0.00014	0.000159	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000138	0.000157	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—EGFR—adrenal gland cancer	0.000132	0.00015	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—TP53—adrenal gland cancer	0.000129	0.000147	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—TP53—adrenal gland cancer	0.000127	0.000144	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000125	0.000142	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000123	0.000139	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—EGFR—adrenal gland cancer	0.000119	0.000135	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—TP53—adrenal gland cancer	0.000119	0.000135	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—EGFR—adrenal gland cancer	0.000114	0.00013	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000114	0.000129	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—EGFR—adrenal gland cancer	0.000111	0.000126	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—TP53—adrenal gland cancer	0.000111	0.000126	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—EGFR—adrenal gland cancer	0.000109	0.000124	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—TP53—adrenal gland cancer	0.0001	0.000114	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—EGFR—adrenal gland cancer	9.93e-05	0.000113	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—EGFR—adrenal gland cancer	9.72e-05	0.00011	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—TP53—adrenal gland cancer	9.6e-05	0.000109	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—TP53—adrenal gland cancer	9.34e-05	0.000106	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—TP53—adrenal gland cancer	9.19e-05	0.000104	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—EGFR—adrenal gland cancer	9.03e-05	0.000103	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—TP53—adrenal gland cancer	8.34e-05	9.47e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—TP53—adrenal gland cancer	8.16e-05	9.27e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—TP53—adrenal gland cancer	7.58e-05	8.61e-05	CbGpPWpGaD
